Metering device for creating a gas flow with an active agent
EP2050436A1
Pharmaceutical composition containing dutasteride
DE102007056263A1
Dosing device for inhaling a powdery substance
TW200815049A
Composition granule and tablet containing candesartan cilexetil and process to fabricate the tablet
US2007036850A1
Film-coated tablet or granules containing as active ingredient a pyridylpyrimidine compound or a pharmaceutically acceptable salt of this compound
DE102006007495A1
Dispersion unit e.g. for medical powder inhalator and aerosol dispersion, uses annular guide chamber to direct entering powder flow in mainly radial direction
EP1720884A1
Pharmacologically acceptable salts of clopidogrel
ZA200500483B
Method for introducing a 1,2 double bond into 3-oxo-4-azasteroid compounds.
WO2005046634A2
Gastric juice-resistant form of administration
EP1618873A1
Granule for the controlled release of tamsulosin, containing alginate
CN1826314A
Method for production of dollar g(a), dollar g(b)-unsaturated amide compounds
CH697952B1
A process for purification of free amlodipine base.
NZ537670A
Process for introducing a 1,2-double bond in 3-oxo-4-azasteroid compounds
CH696359A5
Preparation of 17 beta-substituted 4-aza-androst-1-en-3-one compounds, e.g. finasteride, by 3-stage dehydrogenation of corresponding 1,2-saturated compound
CH695338A5
A process for introducing a 1,2 double bond at 3-oxo-4-azasteroidverbindungen.
CH695422A5
A process for introducing a 1,2 double bond at 3-oxo-4-azasteroidverbindungen.
